- Home
- SHPH vs SXTC Comparison
SHPH vs SXTC Comparison
Compare SHPH & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- SXTC
- Stock Information
- Founded
- SHPH 2012
- SXTC 2005
- Country
- SHPH United States
- SXTC China
- Employees
- SHPH N/A
- SXTC 75
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- SHPH Health Care
- SXTC Health Care
- Exchange
- SHPH Nasdaq
- SXTC Nasdaq
- Market Cap
- SHPH 3.1M
- SXTC 2.5M
- IPO Year
- SHPH 2022
- SXTC 2019
- Fundamental
- Price
- SHPH $1.17
- SXTC $0.72
- Analyst Decision
- SHPH
- SXTC
- Analyst Count
- SHPH 0
- SXTC 0
- Target Price
- SHPH N/A
- SXTC N/A
- AVG Volume (30 Days)
- SHPH 141.0K
- SXTC 1.4M
- Earning Date
- SHPH 11-12-2024
- SXTC 01-01-0001
- Dividend Yield
- SHPH N/A
- SXTC N/A
- EPS Growth
- SHPH N/A
- SXTC N/A
- EPS
- SHPH N/A
- SXTC N/A
- Revenue
- SHPH N/A
- SXTC $1,928,497.00
- Revenue This Year
- SHPH N/A
- SXTC N/A
- Revenue Next Year
- SHPH N/A
- SXTC N/A
- P/E Ratio
- SHPH N/A
- SXTC N/A
- Revenue Growth
- SHPH N/A
- SXTC N/A
- 52 Week Low
- SHPH $1.13
- SXTC $0.53
- 52 Week High
- SHPH $5.35
- SXTC $6.39
- Technical
- Relative Strength Index (RSI)
- SHPH 30.09
- SXTC 50.69
- Support Level
- SHPH $1.29
- SXTC $0.65
- Resistance Level
- SHPH $1.37
- SXTC $0.82
- Average True Range (ATR)
- SHPH 0.12
- SXTC 0.09
- MACD
- SHPH 0.01
- SXTC 0.03
- Stochastic Oscillator
- SHPH 4.93
- SXTC 52.97
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.